2022’ye Kadar Esrar Esrar Pazar Analizi
Fortune Business Insights™ ‘ a göre , 2020’de küresel kenevir pazarının büyüklüğü 20,47 milyar ABD Doları olarak gerçekleşti. Ürünün terapötik ve tıbbi faydaları, etkinleştirme politikaları ve gevşetici düzenlemelere ilişkin farkındalığın artması, muhtemelen pazar gelişimini destekleyecektir. Esrar pazarının 2021’de 28.266 milyar ABD dolarından 2028’de 197.74 milyar ABD dolarına çıkması ve tahmin dönemi boyunca %32.04’lük bir YBBO sergilemesi öngörülmektedir.
Kenevir, belirli miktarlarda tüketildiğinde terapötik ve tıbbi yararları ile tanınan çiçekli bir bitkidir. Kanseri iyileştirmeye yardımcı olur, depresyonu azaltır ve başka birçok tıbbi faydası vardır. Yasallaştırma politikaları nedeniyle birçok ülkede yavaş yavaş tanınmaktadır. Ayrıca, düzenleyici gevşemelerin ve olumlu politikaların benimsenmesinin, ürünün benimsenmesini artırması bekleniyor. Örneğin, Temsilciler Meclisi 2020’de KAHRAMANLAR Yasasını kabul etti ve yasayı SAFE Bankacılık Yasası ve Senato’ya sundu. Bu yasa, bankaların bu şirketlere hizmet vermesine ve olumlu büyümelerine yardımcı olur.
Yetiştirme, üretim ve ticaretin yasallaştırılması muhtemelen pazar gelişimini hızlandıracaktır. Tıbbi ve terapötik marihuana ürünlerine yönelik tesislerin ve çiftliklerin artan gelişimi, muhtemelen önümüzdeki yıllarda pazar gelişimini hızlandıracaktır.
Örnek bir PDF Broşürü Alın:
Esrar Piyasası Raporunda Profili Oluşturulan Kilit Oyuncuların Listesi:
- Aurora Cannabis Inc. (Edmonton, Kanada)
- Tilary, Inc. (Nanaimo, Kanada)
- Canopy Growth Corporation (Ontario, Kanada)
- CannTrust Holdings Inc. (Vaughan, Kanada)
- VIVO Cannabis Inc. (Büyük Napanee, Kanada)
- Cronos Group Inc. (Toronto, Kanada)
- Caz İlaçları (Dublin, İrlanda)
- OrganiGram Holdings (Moncton, Kanada)
- Lexaria Corp. (Kelowna, Kanada)
- ABcann İlaçları, Inc. (Ontario, Kanada)
Rising Demand from Medical Sectors to Boost Market Development
This market is expected to grow steadily during the COVID-19 pandemic because of the rising demand for medical marijuana from the healthcare sector. The sudden spike in COVID-19 cases led to the adoption of stringent restrictions on non-essential sectors. However, the rising demand for the product from the medical sector facilitated sales. The adoption of products for medical purposes may boost the product’s adoption. Further, the adoption of reduced capacities, part-time shifts, and production machinery enabled players to balance costs and recover losses. These factors may propel market development during the pandemic.
By type, the market is segmented into concentrates and flowers/buds. Based on application, it is classified into industrial hemp, recreational, and medical. Regionally, it is classified into Europe, North America, Asia-Pacific, and the Rest of the World.
Highlights of the Report
The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market’s key players.
Browse Detailed Summary of Research Report with TOC:
Rising Adoption from Medical Sectors and Availability of Marijuana Incorporated Edibles to Boost Market Growth
Marijuana is used extensively in the medical sector to manufacture anti-depressant drugs, cancer medicines, and other medicines. The rising awareness regarding its benefits is expected to boost its sales. The availability of a wide variety of flavors and edibles is expected to boost the product’s adoption. The product’s availability in candies, chocolates, and beverages is expected to boost its popularity and enable users to enjoy the substance for an hour or two. Furthermore, marijuana’s demand is increasing rapidly from the medical sector because of relaxation policies. Several countries have placed favorable policies legalizing marijuana’s adoption in medicines. It is used to treat AIDS, cancer, and other disorders, which, in turn, is expected to boost its demand. In addition, its adoption by mainstream medical professionals is increasing because of its ability to treat arthritis, anorexia, and other disorders. These factors are likely to drive the cannabis market growth.
However, regulations prohibiting the sales and cultivation of marijuana in several countries may hinder the market’s progress.
Recreational Legalization in the U.S. to Boost Market Growth in North America
North America is projected to dominate the cannabis market share because of marijuana’s legalization in the U.S. The market in North America stood at USD 19.78 billion in 2020 and is expected to grow positively during the upcoming years. The District of Columbia and Eleven states legalized the adoption of the product in 2019. The state medical cannabis law in the U.S. recognized the product as a medical drug to cure post-traumatic stress disorder, epilepsy, chronic pain, arthritis, and Alzheimer’s disease. In addition, the emergence of several marijuana growers is expected to boost the market growth.
Europe is the second-largest market shareholder because of the rising adoption of the product and the adoption of favorable legislation. Marijuana is observed to be effective in trials and is used extensively in treating cancers, AIDS, and other disorders in the medical sector. The Greek legislation legalized the adoption of marijuana in 2018, which, in turn, may boost the product’s adoption. These factors are likely to facilitate market development.
Companies Acquire Crucial Players to Expand their Product Portfolio
The prominent companies operating in the market devise acquisition strategies to expand their product portfolio. For example, Supreme Cannabis Company, Inc. and the Canopy Growth Corporation entered an agreement to acquire Supreme Cannabis by Canopy Company, Inc. in April 2021. This acquisition shall help Canopy Growth Corporation expand its product portfolio, attract consumers, and improve its brand position globally. Further, the launch of innovative products may enable manufacturers to satisfy consumer demand and enhance their brand image.
Speak to Our Expert:
Key Industry Development
- December 2020: A leading company named Aphria Inc. and Tilray, Inc reached an agreement to combine their business and transform into the world’s biggest marijuana manufacturer. The company shall be backed by state-of-the-art manufacturing, processing, and affordable costs to offer a portfolio of marijuana products in Canada.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, Hindistan.
ABD: +1 424 253 0390
BK: +44 2071 939123
APAC: +91 744 740 1245
E-posta : [email protected]